Today we are delighted to introduce another key Code-N Advisory Board member: Dr. Paul Pearson. A veteran executive with Amgen, Merck, Pharmacia and Upjohn, Paul is now president of a consultancy advising biotechnology and pharmaceutical companies and the NIH on drug discovery, metabolism, drug interactions, toxicity, and safety. Be sure to read the profile of our […]
Read more »